Physician profile
Ariffin Alam
NPI 1659698579
$11,355.59
in general payments reported to CMS, 2019-2025
31 companies · $379 in 2025
The $379 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.18 · 2020: $999 · 2021: $430 · 2022: $2,103 · 2023: $6,890 · 2024: $479 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,000 · Food and Beverage: $1,247 · Travel and Lodging: $501.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,000.00 |
| Food and Beverage | $1,247.25 |
| Travel and Lodging | $500.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,843.37 | 2022-2025 | Da Vinci Surgical System, Ion, Da Vinci Sp |
| Pulmonx Corporation | $1,658.37 | 2020-2024 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Inspire Medical Systems, INC. | $932.39 | 2020-2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $231.31 | 2019-2024 | Fasenra, Breztri |
| Glaxosmithkline, LLC. | $206.02 | 2022-2024 | Trelegy Ellipta, Nucala, Arexvy |
| United Therapeutics Corporation | $199.80 | 2022-2024 | Tyvaso |
| Zoll Respicardia, INC. | $180.41 | 2021 | |
| Abiomed | $136.05 | 2025 | |
| Mylan Specialty L.P. | $114.38 | 2022-2024 | Yupelri |
| Amgen INC. | $113.73 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $89.74 | 2023-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $78.33 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.62 | 2020-2025 | Ofev |
| Abbott Laboratories | $51.75 | 2022-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Shionogi INC | $50.19 | 2023-2024 | Fetroja |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $39.73 | 2022-2023 | Xarelto |
| Philips North America LLC | $39.49 | 2020-2025 | Home Pi Undivided |
| Insmed, INC. | $37.62 | 2023 | Arikayce |
| Baxter Healthcare | $35.43 | 2023 | Hillrom - Life 2000 Ventilation System |
| Inogen, INC. | $27.20 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Electromed, INC. | $25.21 | 2022 | |
| Abbvie INC. | $24.36 | 2022 | |
| Novartis Pharmaceuticals Corporation | $24.18 | 2022 | |
| Merck Sharp & Dohme LLC | $23.99 | 2019 | |
| Genzyme Corporation | $23.32 | 2024 | |
| Pfizer INC. | $23.17 | 2023 | |
| Ani Pharmaceuticals, INC. | $18.86 | 2024 | Purified Cortrophin Gel |
| Sunovion Pharmaceuticals INC. | $18.67 | 2019 | |
| Grifols USA, LLC | $18.60 | 2023 | Prolastin-C Liquid |
| Circassia INC. | $16.07 | 2019 | |
| Veran Medical Technologies, INC. | $5.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ariffin Alam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.